Kerr W. Holbrook - 18 Mar 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Commercial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Issuer symbol
AVNS
Transactions as of
18 Mar 2024
Net transactions value
-$68,648
Form type
4
Filing time
19 Mar 2024, 16:10:50 UTC
Previous filing
07 Mar 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise $0 +2,531 +2.9% $0.000000 89,727 18 Mar 2024 Direct F1
transaction AVNS Common Stock Tax liability $14,432 -756 -0.84% $19.09 88,971 18 Mar 2024 Direct F2
transaction AVNS Common Stock Tax liability $54,216 -2,840 -3.2% $19.09 86,131 18 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,531 PRSUs which vested on March 18, 2024.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 9,516 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock.